Additionally, the effects of SETD4 on the EMT pathway showed opposite patterns across different cancers, with activation in HNSC, LIHC, THCA, and THYM and inhibition in DLBC, LGG, SARC, TGCT, and UCEC (Figure 4B). Here, SETD4 is linked to cancer.